Top

Gepubliceerd in:

2021 | OriginalPaper | Hoofdstuk

6. Hypersomnie

Auteurs : Dr. Al de Weerd, Drs. Maaike van Veen

Gepubliceerd in: Slaapstoornissen in de psychiatrie

Uitgeverij: Bohn Stafleu van Loghum

Samenvatting

Hypersomnie, ofwel overmatige slaperigheid overdag, is een klinisch symptoom dat veel hinder in het dagelijks leven met zich meebrengt. Een exacte bepaling van de prevalentie van dit symptoom is niet goed mogelijk, omdat er vele vormen en oorzaken van zijn. De zogenaamde centrale vormen van hypersomnie krijgen van oudsher de meeste aandacht, hoewel ze relatief weinig voorkomen. Tot deze vormen behoren narcolepsie type 1 en 2, idiopathische hypersomnie en periodieke hypersomnie (Kleine-Levin-syndroom). Hypersomnie ten gevolge van andere aandoeningen, zowel somatische als psychiatrische, wordt frequenter gezien. Dit hoofdstuk geeft een overzicht van de symptomen, differentiële diagnostiek en behandeling van deze verschillende vormen van hypersomnie, met aandacht voor de psychiatrische aspecten.

vorige hoofdstuk Slaapgerelateerde ademhalingsstoornissen

volgende hoofdstuk Circadiane slaap-waakritmestoornissen

American Association of Sleep Medicine (2014). Hypersomnias. International Classification of Sleep Disorders (ICSD)-3. 143–188.

Arnulf, I., Zeitzer, J., File, J., Farber, N., & Mignot, E. (2005). Kleine Levin Syndrome: A systematic review of 186 cases in the literature. Brain, 128, 2763–2776.CrossRef

Barateau, L., Lopez, R., Franchi, J., & Dauvilliers, Y. (2017). Hypersomnolence, hypersomnia and mood disorders. Current Psychiatry Reports, 19, 13.CrossRef

Barros Lima, F., Borges do Nascimento, E., Texeira, S., Morgadinho Coelho, F., & Paz Oliviera, G. (2019). Thinking outside the box: Cataplexy without narcolepsy. Sleep Medicine, 61, 118–121.CrossRef

Billiard, M., & Sonka, K. (2016). Idiopathic hypersomnia. Sleep Medicine Reviews, 29, 23–33.CrossRef

Canellas, F., Lin, L., Julia, M., Clemente, A., Vives-Bauza, C., Ollila, H., et al. (2014). Dual cases of type 1 narcolepsy with schizophrenia and other psychotic disorders. Journal of Clinical Sleep Medicine, 10, 1011–1018.CrossRef

De Oliveira, M. M., Conti, C., & Prado, G. F. (2016). Pharmacological treatment for Kleine-Levin syndrome. Cochrane Database Systematic Review, 6(5), 1465–1858.

Diagnostic and statistical manual of mental disorders, DSM-5 (2017). Hypersomnolence disorder. 368–372.

Droogleever Fortuyn, H. A., Fronczek, R., Smitshoek, M., Overeem, S., Lappenschaar, M., Kalkman, J., et al. (2012). Severe fatigue in narcolepsy with cataplexy. Journal of Sleep Research, 21(2), 163–169.CrossRef

Factsheet Resultaten Slaaponderzoek, Hersenstichting (2017). https://www.hersenstichting.nl/app/uploads/2020/03/Def-Factsheet-Slaaponderzoek-Volwassenen1c21.pdf.

Filardi, M., Pizza, F., Tonetti, L., Antelmi, E., Natale, V., & Plazzi, G. (2017). Attention impairments and ADHD symptoms in adult narcoleptic patients with and without hypocretin deficiency. PLoS One, 12(8), e0182085.

Ford, E. S., Cunningham, T. J., & Croft, J. B. (2015). Trends in self-reported sleep duration among US Adults from 1985 to 2012. Sleep, 38(5), 829–832.CrossRef

Fortuyn, H. A., Lappeschaar, M. A., Furer, J. W., Hodiamont, P. P., Rijnders, C. E., Renier, W. O., et al. (2010). Anxiety and mood disorders in narcolepsy. General Hospital Psychiatry, 32, 49–56.CrossRef

Fortuyn, H. A., Mulders, P. C., Renier, W. O., Buitelaar, J. K., & Overeem, S. (2011). Narcolepsy and psychiatry: An evolving association of increasing interest. Sleep Medicine, 12(7), 714–719.CrossRef

Geoffroy, P. A., Hoertel, N., Etain, B., Bellivier, F., Delorme, R., Limosin, F., et al. (2018). Insomnia and hypersomnia in major depressive episode: prevalence, sociodemographic caracteristics and psychiatric comorbidity in a population-based study. Journal of Affective Disorders, 226, 132–141.CrossRef

Groos, E., Chaumereuil, C., Flamand, M., Brion, A., Bourdin, H., Slimani, V., et al. (2018). Emerging psychiatric disorders in Kleine-Levin syndrome. Journal of Sleep Research, 27(5), e12690.

Hombali, A., Seow, E., Yuan, Q., Chang, S. H. S., Satghare, P., Kumar, S., et al. (2019). Prevalence and correlates of sleep disorder symptoms in psychiatric disorders. Psychiatry Research, 279, 116–122.CrossRef

Kallweit, U., & Bassetti, C. L. (2017). Pharmacological management of narcolepsy with and without cataplexy. Expert Opinion on Pharmacotherapy, 18(8), 809–817.CrossRef

Lee, M., Lee, S., Yuan, S., Yang, C., Yang, K., Lee, T., et al. (2017). Comorbidity of narcolepsy and depressive disorders: A nation wide population-based study in Taiwan. Sleep Medicine, 39, 95–100.CrossRef

Morse, A., & Sanjeev, K. (2018). Narcolepsy and psychiatric disorders: Comorbidities or shared pathophysiology? Medical Sciences, 6, 16–29.CrossRef

Oosterloo, M., Lammers, G. J., Overeem, S., De Noord, I., & Kooij, J. J. S. (2006). Possible confusion between primary hypersomnia and adult attention-deficit/hyperactivity disorder. Psychiatry Research, 143, 293–297.CrossRef

Parmar, A., Yeh, E. A., Korczak, D. J., Weiss, S. K., Lu, Z., Zweerinck, A., et al. (2019). Depressive symptoms, sleep patterns, and physical activity in adolescents with narcolepsy. Sleep, 42(8), zsz111.

Plante, D. T. (2017). Sleep propensity in psychiatric hypersomnolence: A systematic review and meta-analysis of MSLT findings. Sleep Medicine Reviews, 31, 48–57.CrossRef

Plante, D. T. (2018). Nocturnal sleep architecture in idiopathic hypersomnia: A systematic review and meta-analysis. Sleep Medicine Reviews, 45, 17–24.CrossRef

Reading, P. J. (2019). Update on narcolepsy. Journal of Neurology, 266, 1809–1815.

Ruoff, C. M., Reaven, N. L., Funk, S. E., McGaughey, K., Ohayon, M., Guilleminault, C., et al. (2017). High rates of psychiatric comorbidity in narcolepsy: Findings from the burden of narcolepsy disease (BOND) Study of 9,312 Patients in the United States. Journal of Clinical Psychiatry, 78(2), 171–176.CrossRef

Soehner, A. M., Kaplan, K. A., & Harvey, A. G. (2014). Prevalence and clinical correlates of co-occurring insomnia and hypersomnia symptoms in depression. Journal of Affective Disorders, 167, 93–97.CrossRef

Takenoshita, S., & Nishino, S. (2017). Pharmacologic management of excessive daytime sleepiness. Sleep Medicine Clinics, 12, 461–478.CrossRef

Thorpy, M. J., & Bogan, R. K. (2019). Update on the pharmacologic management of narcolepsy: Mechanisms of action and clinical implications. Sleep Medicine, 68, 97–109.CrossRef

Van Holst, R. J., Van der Cruijsen, L., Van Mierlo, P., Lammers, G. J., Cools, R., Overeem, S., et al. (2016). Aberrant food choices after satiation in human orexin-deficient narcolepsy type 1. Sleep, 39(11), 1951–1959.CrossRef

Xu, X., Wei, Y., Liu, Y., & Li, Z. (2019). Gamma-hydroxybutyrate (GHB) in narcolepsy in adults. An updated systematic review and meta-analysis. Sleep Medicine, 64, 62–70.CrossRef

Titel: Hypersomnie
Auteurs: Dr. Al de Weerd
Drs. Maaike van Veen
Uitgeverij: Bohn Stafleu van Loghum
Boek: Slaapstoornissen in de psychiatrie
Print ISBN: 978-90-368-2523-8

Elektronisch ISBN: 978-90-368-2524-5

Copyright: 2021
DOI: https://doi.org/10.1007/978-90-368-2524-5_6

Bohn Stafleu van Loghum

Deel dit onderdeel of sectie (kopieer de link)

Samenvatting

Log in om toegang te krijgen